TY - JOUR
T1 - Erythrocyte sedimentation rate in COVID-19 patients treated at the CLAS health center, Nuevo Lurín, 2021
AU - Esteves Pairazaman, Ambrocio Teodoro
AU - Parren̈o Tipian, Juan Manuel
AU - Arbieto Mamani, Oscar
AU - Leȯn Mejia, Enrique
AU - Esteves Cardenas, Veronica Liset
AU - Ñañez del Pino, Daniel
AU - Ramos Jaco, Antonio Guillermo
AU - Ibarra Fretell, Walter Gregorio
AU - CRUZ MAMANI, MARIBEL
AU - ZAMBRANA ALFONZO, JACQUELINE TERESA
N1 - Publisher Copyright:
Copyright: © 2022 Esteves Pairazaman AT et al.
PY - 2022
Y1 - 2022
N2 - Background: The erythrocyte sedimentation rate (ESR) is used for diagnosis in inflammatory processes, including during the coronavirus disease 2019 (COVID-19) pandemic affecting our population. To determine the values of ESR in the evolution of patients with COVID-19 undergoing treatment at the CLAS Health Center in Nuevo Lurín. Methods: Our research applied a quantitative-observational, descriptive, and longitudinal approach. The sample consisted of 26 male and 19 female patients treated at the study site between February and June 2021, none of whom were in critical condition. To collect all the necessary information, the Capillary or Wintrobe method was used to determine the values of ESR in the evolution of the COVID-19 patients, obtaining different values for the 45 patients seen at the study site. The normal ESR value was 0 - 15mm/h for males and 0 - 20mm/h for females. Results: The initial ESR test in patients positive for COVID-19 showed that only two cases (0.04%) had slightly elevated ESR ranges, while in the rest of the values (95.56%) remained within the normal range. Conclusions: From the results of the capillary velocity of sedimentation method, it can be concluded that patients with COVID-19 in Peru showed no signs of inflammation within their bodies due to the virus.
AB - Background: The erythrocyte sedimentation rate (ESR) is used for diagnosis in inflammatory processes, including during the coronavirus disease 2019 (COVID-19) pandemic affecting our population. To determine the values of ESR in the evolution of patients with COVID-19 undergoing treatment at the CLAS Health Center in Nuevo Lurín. Methods: Our research applied a quantitative-observational, descriptive, and longitudinal approach. The sample consisted of 26 male and 19 female patients treated at the study site between February and June 2021, none of whom were in critical condition. To collect all the necessary information, the Capillary or Wintrobe method was used to determine the values of ESR in the evolution of the COVID-19 patients, obtaining different values for the 45 patients seen at the study site. The normal ESR value was 0 - 15mm/h for males and 0 - 20mm/h for females. Results: The initial ESR test in patients positive for COVID-19 showed that only two cases (0.04%) had slightly elevated ESR ranges, while in the rest of the values (95.56%) remained within the normal range. Conclusions: From the results of the capillary velocity of sedimentation method, it can be concluded that patients with COVID-19 in Peru showed no signs of inflammation within their bodies due to the virus.
KW - capillary method
KW - COVID-19
KW - erythrocyte sedimentation rate
KW - ESR
KW - Wintrobe
UR - http://www.scopus.com/inward/record.url?scp=85152945425&partnerID=8YFLogxK
U2 - 10.12688/f1000research.125002.1
DO - 10.12688/f1000research.125002.1
M3 - Article
AN - SCOPUS:85152945425
SN - 2046-1402
VL - 11
JO - F1000Research
JF - F1000Research
M1 - 1278
ER -